These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20571593)

  • 1. Immunohistochemical expression of survivin in breast carcinoma: relationship with clinicopathological parameters, proliferation and molecular classification.
    Youssef NS; Hewedi IH; Abd Raboh NM
    J Egypt Natl Canc Inst; 2008 Dec; 20(4):348-57. PubMed ID: 20571593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.
    Nassar A; Lawson D; Cotsonis G; Cohen C
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):113-20. PubMed ID: 18227733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma.
    Adamkov M; Kajo K; Vybohova D; Krajcovic J; Stuller F; Rajcani J
    Neoplasma; 2012; 59(1):30-7. PubMed ID: 22103896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin expression in breast carcinoma: correlation with apoptosis and prognosis.
    Nassar A; Sexton D; Cotsonis G; Cohen C
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):221-6. PubMed ID: 18301249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin expression in breast lobular carcinoma: correlations with normal breast tissue and clinicomorphological parameters.
    Adamkov M; Výbohová D; Horáček J; Kovalská M; Furjelová M
    Acta Histochem; 2013 Jun; 115(5):412-7. PubMed ID: 23219440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin and clinical correlation in patients with breast cancer.
    Sohn DM; Kim SY; Baek MJ; Lim CW; Lee MH; Cho MS; Kim TY
    Biomed Pharmacother; 2006 Jul; 60(6):289-92. PubMed ID: 16876381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular subtypes of breast carcinoma in Saudi Arabia. A retrospective study.
    Alnegheimish NA; Alshatwi RA; Alhefdhi RM; Arafah MM; AlRikabi AC; Husain S
    Saudi Med J; 2016 May; 37(5):506-12. PubMed ID: 27146612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast.
    Al-Joudi FS; Iskandar ZA; Hasnan J; Rusli J; Kamal Y; Imran AK; Ahmed M; Zakaria J
    Singapore Med J; 2007 Jul; 48(7):607-14. PubMed ID: 17609820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin in breast lesions: immunohistochemical analysis of 196 cases.
    Adamkov M; Drahošová S; Chylíková J; Výbohová D
    Pol J Pathol; 2017; 68(4):297-305. PubMed ID: 29517199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
    Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
    World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship of c-FLIP(L) protein expression with molecular subtyping and clinical prognosis in invasive breast cancer].
    Zang F; Wei X; Sun B
    Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):442-6. PubMed ID: 25327791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
    Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
    APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.
    Koo HR; Cho N; Song IC; Kim H; Chang JM; Yi A; Yun BL; Moon WK
    J Magn Reson Imaging; 2012 Jul; 36(1):145-51. PubMed ID: 22392859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer.
    Yakirevich E; Samkari A; Holloway MP; Lu S; Singh K; Yu J; Fenton MA; Altura RA
    Hum Pathol; 2012 Jun; 43(6):865-73. PubMed ID: 22055399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features of indonesian breast cancers with different molecular subtypes.
    Widodo I; Dwianingsih EK; Triningsih E; Utoro T; Soeripto
    Asian Pac J Cancer Prev; 2014; 15(15):6109-13. PubMed ID: 25124582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of β-catenin in invasive ductal breast carcinomas.
    Abd El-Rehim D; Ali MM
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):185-95. PubMed ID: 21057570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].
    Zhang B; Liu YX; Cao WF; Cao XC; Ning LS; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):471-6. PubMed ID: 19035119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer.
    Kammori M; Kurabayashi R; Kashio M; Sakamoto A; Yoshimoto M; Amano S; Kaminishi M; Yamada T; Takubo K
    Oncol Rep; 2008 Mar; 19(3):651-6. PubMed ID: 18288397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.